Key points for designing and reporting Helicobacter pylori therapeutic trials: A personal view

Xavier Calvet, Javier P. Gisbert, David Suarez

Producció científica: Contribució a una revistaArticleRecercaAvaluat per experts

11 Cites (Scopus)

Resum

Background and objectives: The aim of this document is to provide a methodological framework and to review key aspects for adequately designing trials to evaluate new treatments for Helicobacter pylori infection. Methods: Non-systematic literature review. Results and conclusions: Regarding the design of the article, we suggest selecting for future trials drugs to which H. pylori has no significant primary resistances and evaluating therapies with pilot studies before engaging in randomized trials. The manuscript defines how the number and type of H. pylori diagnostic tests necessary before and after the trial depend on the setting and reliability of the tests. It recommends the best methods and timing for H. pylori testing before and after therapy. Other recommendations are using current standard treatments as comparators of new therapies, determining antibiotic sensitivity - whenever useful and possible - using adequate randomization and allocation concealment but not necessarily blinding, and performing an intention-to-treat and a per-protocol analysis. In addition, we give basic tips for reporting and discussing study results. © 2011 Blackwell Publishing Ltd.
Idioma originalEnglish
Pàgines (de-a)346-355
RevistaHelicobacter
Volum16
DOIs
Estat de la publicacióPublicada - 1 d’oct. 2011

Fingerprint

Navegar pels temes de recerca de 'Key points for designing and reporting Helicobacter pylori therapeutic trials: A personal view'. Junts formen un fingerprint únic.

Com citar-ho